Original Research
Published on 04 Aug 2023
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients
in Gastrointestinal Cancers: Colorectal Cancer
- 3,531 views
- 8 citations